New Label-Free Biosensing for the Evaluation of the AX-024 Inhibitor: Case Study for the Development of New Drugs in Autoimmune Diseases

We developed a new label-free assay to evaluate the inhibition capacity of AX-024 by means of a new Point-of-Care (PoC) device for application in the development of new drugs in autoimmune diseases. The technology of PoC is based on interferometric optical detection method (IODM). For this purpose,...

Full description

Bibliographic Details
Main Authors: Yolanda Ramírez, María Fe Laguna, Miguel Holgado
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Sensors
Subjects:
Online Access:https://www.mdpi.com/1424-8220/22/3/1218

Similar Items